Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Prophase Labs Inc (PRPH)

6.76   0.21 (3.21%) 03-07 04:02
Open: 6.6 Pre. Close: 6.55
High: 6.83 Low: 5.9299
Volume: 127,888 Market Cap: 102M
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. The company is headquartered in Doylestown, Pennsylvania and currently employs 54 full-time employees. The firm is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The firm's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The firm's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.833 - 6.874 6.874 - 6.914
Low: 5.844 - 5.887 5.887 - 5.928
Close: 6.686 - 6.757 6.757 - 6.826

Technical analysis

as of: 2021-03-05 5:12:11 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.95     One year: 13.43
Support: Support1: 5.93    Support2: 4.93
Resistance: Resistance1: 9.37    Resistance2: 11.50
Pivot: 8.42
Moving Average: MA(5): 7.20     MA(20): 9.01
MA(100): 9.57     MA(250): 5.14
MACD: MACD(12,26): -1.11     Signal(9): -0.89
Stochastic oscillator: %K(14,3): 6.51     %D(3): 7.02
RSI: RSI(14): 30.16
52-week: High: 16.04  Low: 1.20  Change(%): 236.3
Average Vol(K): 3-Month: 19691  10-Days: 16625

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PRPH has closed above bottom band by 17.6%. Bollinger Bands are 16.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 24 Feb 2021
Analyst: All Systems Are Go for Testing, Testing and More Testing - Streetwise Reports

Wed, 17 Feb 2021
With Pivot To COVID-19 Testing, ProPhase Labs Could Greatly Reward Shareholders - Seeking Alpha

Wed, 17 Feb 2021
Analysts Expect ProPhase Labs, Inc. (NASDAQ:PRPH) To Breakeven Soon - Yahoo Finance

Tue, 16 Feb 2021
ProPhase Labs presents at Proactive"s One2One virtual investor forum - Proactive Investors USA & Canada

Thu, 11 Feb 2021
ProPhase Labs: Meet the team that"s looking to revolutionize coronavirus testing - Proactive Investors USA & Canada

Tue, 09 Feb 2021
ProPhase Labs debuts single saliva test for COVID, flu - Mass Device

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 15
Shares Float (M) 9
% Held by Insiders 24.22
% Held by Institutions 4.17
Shares Short (K) 86
Shares Short P. Month (K) 127

Stock Financials

EPS -0.140
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.930
Profit Margin -12.92
Operating Margin -14.30
Return on Assets (ttm) -5.8
Return on Equity (ttm) -13.8
Qtrly Rev. Growth 38.8
Gross Profit (p.s.) 0.173
Sales Per Share 0.824
EBITDA (p.s.) -0.095
Qtrly Earnings Growth
Operating Cash Flow (M) 4
Levered Free Cash Flow (M) 4

Stock Valuations

PE Ratio -48.29
PEG Ratio
Price to Book value 7.27
Price to Sales 8.20
Price to Cash Flow 27.31

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2019-12-11
Ex-Dividend Date 2019-12-01
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.